Well-being, Health and Biomedical Discovery


Academic Unit: Inquire with your unit

Memorial Deadline: No RGCS review required for the LOI

External Deadline: Friday 23rd, April 2021


Harrington Discovery Institute (HDI) and the Alzheimer’s Drug Discovery Foundation (ADDF) invite you to submit an LOI for the 2021 ADDF-Harrington Scholar Award. This grant is designed to accelerate the translation of academic discoveries into medicines for treating, preventing, or curing patients with Alzheimer’s disease and related dementias. Of particular interest are targets related to proteostasis and epigenetics. Researchers working on drug development programs that are relevant to, but not presently focused on, the Alzheimer’s field are encouraged to apply. In addition to grant funding, HDI provides guidance and oversight in all aspects of drug development, while taking no rights to intellectual property, which is retained by you/your institution.

Pending how far an applicant makes it in the review process, Harrington Discovery Institute may be able to provide reviewers’ comments and feedback to help the applicant strengthen the proposal for future submission.

  • Attached:
  • One-Page Overview
  • Frequently Asked Questions
  • Grant Application Outline

Check out these short videos from Harrington Scholars.

To submit an online application, go to ADDF’s funding system and create an account.

Application questions? Contact or

Scientific inquiries? Contact Meriel Owen, PhD, ADDF at



2021 ADDF-Harrington One-Pager

ADDF-Harrington Application Guidelines

ADDF-Harrington FAQs

Funding Sources

Harrington Discovery Institute

This opportunity was posted by: RGCS

Last modified: February 23, 2021